protein biomarkers
Gene Variant Test Shows Promise for Improving Accuracy of CA19-9 for Pancreatic Cancer Detection
Premium
Investigators are assessing performance in a prospective cohort with hopes that the method can be used to complement currently used imaging surveillance.
The envisioned test will involve measuring protein biomarkers in samples obtained by liquid biopsy, as well as artificial intelligence-based analysis tools.
Diagnostics Developer Early is Good Raises $4M in Seed Funding
The company will use the funds to complete clinical trials for its first product, BCDx, a laboratory-developed test for early bladder cancer detection.
OncoHost Raises $35M in Series C Financing
The Israeli firm will use the funds to expand its PROPHETIC trial and support the US commercial launch of the Prophet platform.
The firm obtained FDA breakthrough device designation in 2019 for its protein misfolding cyclic amplification technology and SynTap assay.